Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 4Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Kaposi 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Inflammatory Breast Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Familial ependymoma 1Fallopian Tube Neoplasms 1Esthesioneuroblastoma, Olfactory 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1Breast Neoplasms, Male 1Breast Neoplasms 1Astrocytoma 1Adenocarcinoma, Follicular 1AIDS-related Kaposi sarcoma 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × Semaxinib × Clear all
NCT00026377 2013-09-05

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

University of Chicago

Phase 1 Completed
3 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡